Autolus Therapeutics (AUTL) Other Gross PP&E Adjustments: 2018-2025
Historic Other Gross PP&E Adjustments for Autolus Therapeutics (AUTL) over the last 6 years, with Sep 2025 value amounting to -$10.5 million.
- Autolus Therapeutics' Other Gross PP&E Adjustments rose 40.39% to -$10.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$48.4 million, marking a year-over-year increase of 41.72%. This contributed to the annual value of -$18.0 million for FY2024, which is 53.73% up from last year.
- Autolus Therapeutics' Other Gross PP&E Adjustments amounted to -$10.5 million in Q3 2025, which was up 9.37% from -$11.6 million recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' Other Gross PP&E Adjustments registered a high of $30.0 million during Q2 2021, and its lowest value of -$35.1 million during Q3 2023.
- Its 3-year average for Other Gross PP&E Adjustments is -$17.6 million, with a median of -$16.4 million in 2024.
- As far as peak fluctuations go, Autolus Therapeutics' Other Gross PP&E Adjustments soared by 189.72% in 2021, and later plummeted by 11,935.57% in 2024.
- Over the past 5 years, Autolus Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at $15.3 million in 2021, then crashed by 53.36% to $7.1 million in 2022, then slumped by 536.08% to -$31.1 million in 2023, then skyrocketed by 55.79% to -$13.8 million in 2024, then spiked by 40.39% to -$10.5 million in 2025.
- Its last three reported values are -$10.5 million in Q3 2025, -$11.6 million for Q2 2025, and -$12.5 million during Q1 2025.